HUM

Humana Inc
NYSEHEALTHCAREHEALTHCARE PLANS

Key Statistics

Market Cap
$46.74B
P/E Ratio
40.66
EPS
$9.56
Beta
0.72
52W High
$428.88
52W Low
$161.90
50-Day MA
$364.16
200-Day MA
$263.99
Dividend Yield
0.93%
Profit Margin
0.82%
Forward P/E
41.84
PEG Ratio
2.16

About Humana Inc

Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$137.20B
Gross Profit (TTM)$19.22B
EBITDA$3.36B
Operating Margin4.67%
Return on Equity6.28%
Return on Assets3.64%
Revenue/Share (TTM)$1139.81
Book Value$154.75
Price-to-Book2.46
Price-to-Sales (TTM)0.34
EV/Revenue0.399
EV/EBITDA
Quarterly Earnings Growth (YoY)-4.60%
Quarterly Revenue Growth (YoY)23.50%
Shares Outstanding$120.06M
Float$119.80M
% Insiders0.21%
% Institutions99.90%

Historical Volatility

HV 10-Day
39.13%
HV 20-Day
35.62%
HV 30-Day
33.73%
HV 60-Day
42.48%
HV Rank
3.6%

Volatility is currently expanding

Analyst Ratings

Consensus ($347.96 target)
1
Strong Buy
7
Buy
16
Hold
2
Sell

Latest News

Q2 Earnings Season in Full Swing

Pre-market futures are flat-to-down ahead of today's open, with overseas turbulence in the memory chip market reverberating on domestic shores. We also see something of a hesitation in trading ahead of this afternoon's Fed decision on interest rates.

Zacks Investment Research7/29/2026Negative
Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research7/29/2026Neutral
Humana (HUM) Q2 Earnings and Revenues Top Estimates

Humana (HUM) came out with quarterly earnings of $7.61 per share, beating the Zacks Consensus Estimate of $6.22 per share. This compares to earnings of $6.27 per share a year ago.

Zacks Investment Research7/29/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HUM and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026